| Wild-type growth phase | spo0A growth phase |  | ||||
---|---|---|---|---|---|---|---|
Compound1 | Log | Stationary | Late stationary | Log | Stationary | Late stationary | Sterile medium |
2-Oxoisovalerate | 0.32 ± 0.005 | 0.46 ± 0.03 | 0.56 ± 0.003 | 1.75 ± 0.16 | 18.7 ± 1.78 | 17.8 ± 0.89 | 0.08 ± 0.008 |
2-Oxobutyrate | 0.20 ± 0.009 | 0.17 ± 0.03 | 0.19 ± 0.002 | 0.95 ± 0.24 | 1.63 ± 0.22 | 1.58 ± 0.19 | 0.04 ± 0.015 |
4-Methyl-2-oxovalerate | 0.40 ± 0.05 | 2.43 ± 0.76 | 1.25 ± 0.24 | 0.04 ± 0.015 | 0.07 ± 0.03 | 0.06 ± 0.02 | 0.02 ± 0.01 |
2-Hydroxyglutarate | 1.02 ± 0.27 | 16.51 ± 2.83 | 26.5 ± 4.12 | 0.76 ± 0.03 | 4.20 ± 0.41 | 3.83 ± 0.27 | 0.23 ± 0.01 |
2,3-Dihydroxyisovalerate | 1.1 ± 0.27 | 0.35 ± 0.16 | 0.04 | 0.39 ± 0.04 | 0.15 ± 0.07 | 0.02 ± 0.006 | ND |
Malate | 9.13 ± 1.39 | 20.2 ± 2.43 | 21.7 ± 1.63 | 3.70 ± 0.40 | 9.38 ± 0.32 | 7.59 ± 0.46 | 0.64 ± 0.05 |
2,3-Butanediol | 0.74 ± 0.16 | 3.62 ± 0.03 | 5.13 ± 0.38 | 1.43 ± 0.24 | 12.71 ± 1.72 | 14.3 ± 2.24 | 0.05 ± 0.005 |
Glycerol-1phosphate | 3.18 ± 0.05 | 3.36 ± 0.13 | 4.65 ± 0.72 | 3.29 ± 0.22 | 5.85 ± 0.62 | 6.72 ± 0.40 | 1.37 ± 0.07 |
Glucose-6phosphate | 24.1 ± 3.76 | 59.3 ± 13.11 | 87.0 ± 8.80 | 9.12 ± 1.40 | 19.48 ± 6.67 | 35.3 ± 8.65 | ND |
Glucose-1phosphate | 37.7 ± 8.35 | 17.3 ± 6.31 | 12.1 ± 0.18 | 48.4 ± 7.74 | 49.8 ± 3.17 | 38.9 ± 2.94 | ND |
11.10 min; 246 and 320 m/z | 5.1 ± 0.28 | 13.1 ± 2.9 | 17.8 ± 2.8 | 0.61 ± 0.07 | 2.3 ± 0.50 | 1.43 ± 0.52 | 0.07 ± 0.02 |
7.52 min; 159 and 174 m/z | 1.1 ± 0.007 | 0.98 ± 0.14 | 1.07 ± 0.09 | 2.43 ± 0.25 | 7.56 ± 0.51 | 7.0 ± 0.31 | 0.13 ± 0.03 |
9.58 min; 117, 259, 244, 288 and 303 m/z | 0.2 ± 0.03 | 1.04 ± 0.01 | 0.52 ± 0.01 | 0.58 ± 0.11 | 4.26 ± 1.1 | 4.66 ± 0.99 | 0.14 ± 0.03 |
9.93 min; 331 and 359 m/z | 11.7 ± 1.2 | 55.1 ± 11.6 | 29.6 ± 10.6 | 0.66 ± 0.18 | 2.59 ± 1.20 | 0.61 ± 0.05 | 0.07 ± 0.006 |
10.90 min; 450 m/z | 7.94 ± 0.23 | 5.48 ± 1.19 | 3.83 ± 0.34 | 16.0 ± 1.55 | 21.6 ± 1.37 | 16.0 ± 1.55 | 0.08 ± 0.006 |